JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

147.65

+1.19%↑

Kodu・Aktsiate loetelu・Microbot Medical Inc

Microbot Medical Inc

Suletud

2.44 -2.79

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

2.39

Max

2.54

Põhinäitajad
By Trading Economics
Sissetulek	-899K -3.5M
Kasumimarginaal	-4,038.095
Töötajad	20
EBITDA	-84K -3.5M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+349.44% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	12. nov 2025

Turustatistika
By TradingEconomics
Turukapital	60M 188M
Eelmine avamishind	5.23
Eelmine sulgemishind	2.44

Tehniline skoor

By Trading Central

Kindlus

Neutral Evidence

2.52 / 2.57 Toetus ja vastupanu

Microbot Medical Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

22. okt 2025, 22:47 UTC

Omandamised, ülevõtmised, äriostud

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project -- Update

22. okt 2025, 22:13 UTC

Omandamised, ülevõtmised, äriostud

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project

22. okt 2025, 21:20 UTC

Tulu

Correction to IBM 3Q Sales Jump Article

22. okt 2025, 20:57 UTC

Tulu

SAP Posts Higher 3Q Revenue, Operating Profit

22. okt 2025, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22. okt 2025, 23:46 UTC

Market Talk

Nikkei May Decline Amid U.S.-China Trade Tensions -- Market Talk

22. okt 2025, 23:41 UTC

Market Talk

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22. okt 2025, 23:38 UTC

Market Talk

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22. okt 2025, 23:15 UTC

Tulu

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 4th Update

22. okt 2025, 22:28 UTC

Market Talk

Alcoa Cautions About Spending More on U.S. Smelters -- Market Talk

22. okt 2025, 22:02 UTC

Tulu

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 3rd Update

22. okt 2025, 21:59 UTC

Omandamised, ülevõtmised, äriostud

Williams Cos.: Entered Into 1.5 Mtpa LNG Offtake Obligation >WMB

22. okt 2025, 21:58 UTC

Omandamised, ülevõtmised, äriostud

Williams Cos. to Buy 10% Interest in Louisiana LNG LLC >WMB

22. okt 2025, 21:57 UTC

Omandamised, ülevõtmised, äriostud

Williams Cos. to Buy 80% Ownership In, Become Operator of Driftwood Pipeline >WMB

22. okt 2025, 21:56 UTC

Omandamised, ülevõtmised, äriostud

Williams Cos.: Strategic Partnership Entered With Woodside Energy to Invest in Louisiana LNG Project >WMB

22. okt 2025, 21:47 UTC

Omandamised, ülevõtmised, äriostud

Woodside: Williams to Assume LNG Offtake Obligations for 10% of Produced Volumes

22. okt 2025, 21:47 UTC

Tulu

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22. okt 2025, 21:47 UTC

Omandamised, ülevõtmised, äriostud

Woodside: Williams to Contribute Its Share of Capex for LNG Facility, Pipeline

22. okt 2025, 21:46 UTC

Omandamised, ülevõtmised, äriostud

Woodside Energy Says Williams Deals Worth US$378 Million Including Capital Reimbursement

22. okt 2025, 21:45 UTC

Omandamised, ülevõtmised, äriostud

Woodside Energy to Sell 80% Interest in Driftwood Pipeline Co. to Williams

22. okt 2025, 21:45 UTC

Omandamised, ülevõtmised, äriostud

Woodside Energy to Sell 10% Interest in Louisiana LNG Holding Co. to Williams

22. okt 2025, 21:28 UTC

Market Talk

Tulu

Correction to Alcoa Tariff Market Talk

22. okt 2025, 21:25 UTC

Tulu

Wall Street Wonders if Grail's Cancer Test Results Are a True Positive -- Barrons.com

22. okt 2025, 21:17 UTC

Tulu

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 2nd Update

22. okt 2025, 21:09 UTC

Market Talk

Tulu

Alcoa Says Delivery Fee Covering Tariff Costs -- Market Talk

22. okt 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

22. okt 2025, 20:59 UTC

Tulu

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22. okt 2025, 20:51 UTC

Tulu

SAP Reports Mixed Earnings. The Stock is Down. -- Barrons.com

22. okt 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22. okt 2025, 20:44 UTC

Tulu

Kaiser Aluminum: For the Full Yr 2025, Now Expects Conversion Rev to Be Flat to Up 5% Yr-Over-Yr and Raises Adjusted EBITDA Outlook to Improve 20% to 25% Yr-Over-Yr >KALU

Võrdlus sarnastega

Hinnamuutus

Microbot Medical Inc Prognoos

Hinnasiht

By TipRanks

349.44% tõus

12 kuu keskmine prognoos

Keskmine 12 USD 349.44%

Kõrge 12 USD

Madal 12 USD

Põhineb 1 Wall Streeti analüütiku instrumendi Microbot Medical Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi Microbot Medical Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

2.52 / 2.57Toetus ja vastupanu

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.